Director, Business Development
MBX Biosciences
This listing was originally posted on MBX Biosciences's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moPosition Summary
MBX Biosciences is looking to hire a Director of Business Development who, in partnership with our Chief Business Officer, is responsible for identifying, developing, and scaling revenue‑generating partnerships, growth initiatives, and new business development opportunities. This role plays a critical part in shaping the company’s growth strategy, expanding market presence, and building long‑term value through strategic relationships.
Reporting to the Chief Business Officer, the Director of Business Development works cross‑functionally with R&D, Commercial, Finance, and Legal to evaluate opportunities, structure partnerships, negotiate agreements, and ensure successful execution. The ideal candidate combines strong scientific acumen, commercial instincts, analytical rigor, executive presence, and a track record of closing complex, high‑value deals.
Key Responsibilities
Education & Qualifications
Travel
You will be expected to travel periodically based on the needs of the business to the extent requested by the Company, including attendance at Together Weeks, Together Days, and functional meetings as requested by the Company.
Company Overview:
MBX Biosciences is a biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies based on its proprietary PEP™ platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company’s pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism preparing for Phase 3 development; and an obesity portfolio that includes MBX 4291 in Phase 1 development and MBX 5765 in preclinical development, as well as additional discovery candidates. The Company is based in Carmel, Indiana and Burlington, Massachusetts. To learn more, please visit the Company website at www.mbxbio.com and follow it on LinkedIn.
EEO Statement:
MBX Biosciences is an Equal Opportunity Employer and is committed to treating all applicants fairly without discrimination. We welcome applications from all individuals, regardless of race, national origin, gender, age, physical characteristics, social origin, disability, union membership, religion, family status, pregnancy, sexual orientation, gender identity, gender expression or any unlawful criterion under applicable law.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at MBX Biosciences?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Hormone Analogues for Rare Endocrine Diseases
Upgrade to Pro to access salary benchmarks and market rate data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo